Pediatric patients with inborn errors of metabolism benefit from ketogenic diet treatment, suggesting wider applications for metabolic disorders.
The KD is an effective and generally well-tolerated therapeutic option in pediatric IEMs, with benefits extending beyond seizure control. Adverse effects are typically manageable, although GI intolerance may limit long-term use. Ketogenic diet should be considered not only for refractory epilepsy but also for selected metabolic indications.
No takes yet. Share an insight, caveat, or question.
Wesół‐Kucharska et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: